SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

about

Associations of tumor suppressor SPARCL1 with cancer progression and prognosis Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.

P2860

Q41613171-45931C0B-21C9-42E6-8AE1-4ADA3B5C124E Q55518600-101B88C5-A305-4BAD-9160-27C7C3701549

P2860

SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

Item

http://www.wikidata.org/entity/Q38826019

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

SPARCL1 is a novel predictor o ...... l in hilar cholangiocarcinoma.

@en

type

Item

label

SPARCL1 is a novel predictor o ...... l in hilar cholangiocarcinoma.

@en

prefLabel

SPARCL1 is a novel predictor o ...... l in hilar cholangiocarcinoma.

@en

P1476

SPARCL1 is a novel predictor o ...... l in hilar cholangiocarcinoma.

@en

P2093

Guanzhen Yu

http://www.w3.org/2001/XMLSchema#string

Jianxia Ma

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Yu

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

Yang Yu

http://www.w3.org/2001/XMLSchema#string

Zhaoshen Li

http://www.w3.org/2001/XMLSchema#string

P2860

PRR11 is a novel gene implicated in cell cycle progression and lung cancer

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer

A perspective on cancer cell metastasis

SC1/hevin. An extracellular calcium-modulated protein that binds collagen I.

Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach.

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma

SPARC and tumor growth: where the seed meets the soil?

P2888

s13277-015-4206-4

P304

4159-4167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4206-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007737575

http://www.w3.org/2001/XMLSchema#string

P698

26490986

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

about

P2860

P2860

SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921